pleural effusions dr. sasan tavana pulmonologist modarres hospital shahid beheshti university
Post on 11-Jan-2016
217 Views
Preview:
TRANSCRIPT
Pleural EffusionsPleural Effusions
Dr. Sasan TavanaDr. Sasan Tavana
pulmonologistpulmonologist
Modarres HospitalModarres Hospital
Shahid Beheshti UniversityShahid Beheshti University
Summary SlideSummary Slide
Summary SlideSummary Slide
Normal composition of pleural fluidNormal composition of pleural fluid
Volume 0.1-0.2 ml/kgVolume 0.1-0.2 ml/kg Cells/mm3 1000-5000Cells/mm3 1000-5000
%mesothelial cells 3-70%%mesothelial cells 3-70%
%monocyte 30-75%%monocyte 30-75%
%lymphocytes 2-30%%lymphocytes 2-30%
%granolocytes 10%%granolocytes 10% Protein 1-2 g/dlProtein 1-2 g/dl
%albumin 50-70%%albumin 50-70%
Glucose ≈ plasms levelGlucose ≈ plasms level LDH <50% plasma levelLDH <50% plasma level PH ≥plasmaPH ≥plasma
Normal composision of pleural fluid
Starling’s EquationStarling’s Equation
F= K[ (Pcap – Ppl ) – F= K[ (Pcap – Ppl ) – θθ ( ∏cap – ∏ pl )] ( ∏cap – ∏ pl )]
F=the rate of fluid movement,F=the rate of fluid movement,
P & ∏=the hydrostatic and oncotic pr.P & ∏=the hydrostatic and oncotic pr.
K=the filtration coefficientK=the filtration coefficient
ΘΘ=the osmotic reflection coefficient for pr.=the osmotic reflection coefficient for pr.
Summary SlideSummary Slide
Summary SlideSummary Slide
Physical ExamPhysical Exam
Decreased breath soundsDecreased breath sounds Dullness to percussionDullness to percussion Decreased tactile fremitusDecreased tactile fremitus EgophonyEgophony Pleural friction rubPleural friction rub
Workup: ImagingWorkup: Imaging
Upright Chest X-RayUpright Chest X-Ray• Blunting of costophrenic anglesBlunting of costophrenic angles
Supine Chest X-RaySupine Chest X-Ray• Increased density over lower lung fieldsIncreased density over lower lung fields
Lateral decubitus Chest X-RayLateral decubitus Chest X-Ray• LayeringLayering
Workup: ImagingWorkup: Imaging
Workup: ImagingWorkup: Imaging
Workup: ImagingWorkup: Imaging
UltrasoundUltrasound• Aids in identification of loculated Aids in identification of loculated
effusionseffusions• Aids in differentiation of fluid from Aids in differentiation of fluid from
fibrosisfibrosis• Aids in identification of thoracentesis Aids in identification of thoracentesis
sitesite• Available at bedsideAvailable at bedside
Workup: ImagingWorkup: Imaging
CT ScanCT Scan• Aids in differentiation ofAids in differentiation of
Lung consolidation vs. Pleural effusionLung consolidation vs. Pleural effusion Cystic vs. Solid lesionsCystic vs. Solid lesions Peripheral lung abscess vs. Loculated Peripheral lung abscess vs. Loculated
emypemaemypema
• Aids in identification ofAids in identification of Necrotic areasNecrotic areas Pleural thickening, nodules, massesPleural thickening, nodules, masses Extent of tumorExtent of tumor
Work up: ImagingWork up: Imaging
Differentiation of transudates and Differentiation of transudates and exudatesexudates
Transudates
<0.5
<0.6
<2/3 the upperlimit for serum
Exudates
>0.5
>0.6
>2/3 the upper limit for serum
Pleural Fluid
Pleural/serumProtein
Pleural/serumLDH
Pleural LDH
Diagnostic evaluation of the Diagnostic evaluation of the pleurapleura
RadiographyRadiography ThoracentesisThoracentesis Video-assisted thoracic surgery Video-assisted thoracic surgery
(thoracoscopy)(thoracoscopy) ThoracotomyThoracotomy
Causes of Transudative Causes of Transudative EffusionsEffusions
Congestive Heart failureCongestive Heart failure Nephrotic SyndromeNephrotic Syndrome CirrhosisCirrhosis Meig’s SyndromeMeig’s Syndrome HydronephrosisHydronephrosis Peritoneal dialysisPeritoneal dialysis Ex vacuoEx vacuo
Exudative Pleural EffusionsExudative Pleural Effusions Very common Very common Parapnemonic Parapnemonic
MalignancyMalignancy
Pulmonary embolismPulmonary embolism
CommonCommon Abdominal diseaseAbdominal disease
TuberculosisTuberculosis
Collagen vascularCollagen vascular
UnusualUnusual Drug-induceDrug-induce
AsbestosisAsbestosis
Dressler syn.Dressler syn.
ChylothoraxChylothorax
UremiaUremia
Radiation therapyRadiation therapy
SarcoidosisSarcoidosis
Yellow-nail syn.Yellow-nail syn.
Ovarian hyperstimulation syn.Ovarian hyperstimulation syn.
Useful tests in evaluation of PEUseful tests in evaluation of PE RBC >100000 Malignancy,Trauma,PTERBC >100000 Malignancy,Trauma,PTE WBC >10000 Pyogenic infectionWBC >10000 Pyogenic infection Neutrophil >50% Acute pleuritisNeutrophil >50% Acute pleuritis
Lymphocyte >90% TB,malignancy Lymphocyte >90% TB,malignancy
Eosinophil >10% Asbestosis,Drug,CSS,PnemothoraxEosinophil >10% Asbestosis,Drug,CSS,Pnemothorax
Resolving InfectionResolving Infection
Mesothelial Cells absent TuberculosisMesothelial Cells absent Tuberculosis Pr. , PF/S >0.5 ExudatePr. , PF/S >0.5 Exudate LDH , PF/S >0.6 ExudateLDH , PF/S >0.6 Exudate LDH , IU >200 ExudateLDH , IU >200 Exudate Glucose <60 TB,Malignancy,Empyema,RA Glucose <60 TB,Malignancy,Empyema,RA PH <7.2 Complicated parapneumonic eff.-RAPH <7.2 Complicated parapneumonic eff.-RA
TB,Malignancy,Esophageal ruptureTB,Malignancy,Esophageal rupture Amylase, PF/S >1 PancreatitisAmylase, PF/S >1 Pancreatitis Bacteriology Positive Cause of infectionBacteriology Positive Cause of infection Cytology Positive Malignancy Cytology Positive Malignancy
Heart failureHeart failure
Increased amounts of fluid in Increased amounts of fluid in the interstitial spacesthe interstitial spaces..
Diagnostic thoracentesis ifDiagnostic thoracentesis if::
Are not bilateralAre not bilateral
Are not comparableAre not comparable
FeverFever
Pleuretic Chest PainPleuretic Chest Pain
Bad prognostic factors for Bad prognostic factors for parapneumonic effusionsparapneumonic effusions
Pus present in pleural spacee Pus present in pleural spacee Positive Gram Stain of pleural fluidPositive Gram Stain of pleural fluid Glucose below 40 mg/dlGlucose below 40 mg/dl Positive pleural fluid culturePositive pleural fluid culture Pleural fluid PH < 7.0Pleural fluid PH < 7.0 Pleural fluid LDH > 3 Pleural fluid LDH > 3 хх ULN ULN Loculated pleural fluidLoculated pleural fluid
Classification of Parapneumonic Classification of Parapneumonic EffusionEffusion
Class 1 SmallClass 1 Small
Nonsignificant less than 10 mm thick on X-rayNonsignificant less than 10 mm thick on X-ray
No thoracentesis indicatedNo thoracentesis indicated Class 2 More than 10 mm thickClass 2 More than 10 mm thick
Typical No bad prognostic factorTypical No bad prognostic factor
Antibiotic aloneAntibiotic alone Class 3 7.0< PH < 7.2Class 3 7.0< PH < 7.2
Borderline complicated No other bad prognostic factorBorderline complicated No other bad prognostic factor
ABs plus serial thracentesisABs plus serial thracentesis Class 4 PH<7.0 or another bad prognostic Class 4 PH<7.0 or another bad prognostic
Simple complicated factor but not loculated or pusSimple complicated factor but not loculated or pus
Tube thoracostomy plus ABsTube thoracostomy plus ABs
Classification of parapneumonic Classification of parapneumonic effusion ( Cont. )effusion ( Cont. )
Class 5 Bad prognostic factor plus Class 5 Bad prognostic factor plus
Complex complicated loculationComplex complicated loculation
Tube thoracostomy plus Tube thoracostomy plus
fibrinolyticfibrinolytic Class 6 Frank pus present Class 6 Frank pus present
Simple empyema Single locule or free flowingSimple empyema Single locule or free flowing
Tube thoracostomy ±Tube thoracostomy ±
decorticationdecortication Class 7 Frank pus present Class 7 Frank pus present
Complex empyema Multiple loculesComplex empyema Multiple locules
Tube thoracostomy ±Tube thoracostomy ±
fibrinolyticsfibrinolytics
often require decorticationoften require decortication
Tuberculous PleuritisTuberculous Pleuritis
Acute illness 2/3 of cases; chronic Acute illness 2/3 of cases; chronic illness in 1/3illness in 1/3
Unilateral effusionUnilateral effusion 1/3 will have parenchymal disease1/3 will have parenchymal disease Exudative, lymphocyte predominant Exudative, lymphocyte predominant
effusioneffusion
Diagnosis of Tuberculous PleuritisDiagnosis of Tuberculous Pleuritis
PPD may be negative in up to 30%PPD may be negative in up to 30% CultureCulture Pleural fluid forPleural fluid for
• Adenosine deaminaseAdenosine deaminase• Interferon-gammaInterferon-gamma• Polymerase chain reaction (PCR) for Polymerase chain reaction (PCR) for
tuberculous DNAtuberculous DNA BiopsyBiopsy
Asbestos-related Pleural DiseaseAsbestos-related Pleural Disease
Benign asbestos pleural effusion (10-Benign asbestos pleural effusion (10-20 year latency)20 year latency)
Pleural plaques (20-30 year after Pleural plaques (20-30 year after latency)latency)
Mesothelioma (30-40 year latency)Mesothelioma (30-40 year latency) Diffuse pleural fibrosisDiffuse pleural fibrosis Rounded atelectasisRounded atelectasis
Asbestos-related Pleural PlaquesAsbestos-related Pleural Plaques
Asbestos-related Pleural PlaquesAsbestos-related Pleural Plaques
MesotheoliomaMesotheolioma Associated with asbestos exposure (even Associated with asbestos exposure (even
very modest exposures)very modest exposures)• Latency of 35-40 yearsLatency of 35-40 years
No association with smokingNo association with smoking Difficult diagnosis by cytology. Therefore, Difficult diagnosis by cytology. Therefore,
usually a biopsy is recommendedusually a biopsy is recommended Three histological subtypesThree histological subtypes
• EpithelialEpithelial• SarcomatousSarcomatous• MixedMixed
Treatment of MesotheliomaTreatment of Mesothelioma
Extrapleural pneumonectomyExtrapleural pneumonectomy• 5% surgical mortality5% surgical mortality• Median survival of 21 months (best with Median survival of 21 months (best with
epithelial histology)epithelial histology)• 5 year survival 22%5 year survival 22%
There may be a role for There may be a role for multimodality therapy using multimodality therapy using chemotherapy and radiation therapychemotherapy and radiation therapy
Benign MesotheliomaBenign Mesothelioma Localized pleural tumors of mesenchymal Localized pleural tumors of mesenchymal
originorigin Clinical manifestationsClinical manifestations
• Asymptomatic in 50%Asymptomatic in 50%• Cough, chest pain, dyspnea in 40% of Cough, chest pain, dyspnea in 40% of
symptomatic patientssymptomatic patients• 2 paraneoplastic syndromes2 paraneoplastic syndromes
Hypoglycemia – caused by secretion of insulin-like Hypoglycemia – caused by secretion of insulin-like growth factor IIgrowth factor II
Hypertrophic pulmonary osteoarthropathyHypertrophic pulmonary osteoarthropathy Solitary massSolitary mass Usually cured by surgical removalUsually cured by surgical removal
Pulmonary EmbolizationPulmonary Embolization
ExudativeExudative
TransudativeTransudative
Hepatic HydrothoraxHepatic Hydrothorax
5%5% of patient with cirrhosisof patient with cirrhosis
Right sideRight side
LargeLarge
Viral InfectionViral Infection
AdenovirusAdenovirus
Undiagnosed P.EUndiagnosed P.E
AIDSAIDS
Kaposi SarcomaKaposi Sarcoma
Para pneumonic effPara pneumonic eff..
TBTB
LymphomaLymphoma
Collagen-Vascular Disease of the Collagen-Vascular Disease of the PleuraPleura
Rheumatoid ArthritisRheumatoid Arthritis Systemic Lupus ErythematosisSystemic Lupus Erythematosis SarcoidosisSarcoidosis Wegener’s GranulomatosisWegener’s Granulomatosis Sjogren’s syndromeSjogren’s syndrome
RA and SLERA and SLE
Incidence 3%-7% 15%-44%Sex 80% male Female
80% with SQ nodulesEffusion Exudate ExudateGlucose < 20 mg/dl – 63% > 70 mg/dl
< 50 mg/dl – 83%C4 Low LowPleural RF + LE cells immunology or + ANATreatment NSAID/Steroids Steroids Response Variable response Excellent
Characteristics RA SLE
Cause of malignant pleural Cause of malignant pleural effusioneffusion
Lung 36%Lung 36% Breast 25%Breast 25% Lymphoma 10%Lymphoma 10% Ovary 5%Ovary 5% Stomach 2%Stomach 2% Unknown Unknown 7% 7%
Clinical Manifestations of Plural Clinical Manifestations of Plural MetastasisMetastasis
Dyspnea 57Cough 43Weight loss 32Chest pain 26Malaise 22Fever 8Chills 5Asymptomatic 23
Symptom Patients with symptom (%)
Chernow, B., Sahn, SA., Am J Med, 1977
Causes of paramalignant Causes of paramalignant pleural effusionpleural effusion
Local effects of tumorLocal effects of tumorLymphatic obstructionLymphatic obstruction
Bronchial obstruction with pneumoniaBronchial obstruction with pneumonia
Bronchial obstruction with atelectasisBronchial obstruction with atelectasis
Trapped lungTrapped lung
ChylothoraxChylothorax
SVC SynSVC Syn Systemic effects of tumorSystemic effects of tumor
Pulmonary embolismPulmonary embolism
HypoalbuminemiaHypoalbuminemia
Complications of therapyComplications of therapyRadiation therapyRadiation therapy
ChemotherapyChemotherapy
Survival with Malignant Pleural Survival with Malignant Pleural EffusionEffusion**
Primary Total Low pH Normal pH
Breast 14 3.5 16.6Lymphoma 7 1.7 8.8Lung 5.3 2.4 6.8GI 3.8 1.2 5.2Other 6.3 1.8 17.5Total 7.3 2.1 9.8
Sahn, SA, Annals Internal Medicine, 1988
*time in months
Diagnosis of Malignant Pleural Diagnosis of Malignant Pleural EffusionEffusion
Pleural fluid cytologyPleural fluid cytology Pleural biopsyPleural biopsy ThoracoscopyThoracoscopy
Treatment of Malignant and Treatment of Malignant and Paramalignent Pleural EffusionsParamalignent Pleural Effusions
Serial thoracentesisSerial thoracentesis Chest tube with pleurodesisChest tube with pleurodesis Thoracoscopy with talc poudrageThoracoscopy with talc poudrage Pleuroperitoneal shuntPleuroperitoneal shunt PleurectomyPleurectomy
PneumothoraxPneumothorax
Primary spontaneous pneumothoraxPrimary spontaneous pneumothorax Secondary pneumothoraxSecondary pneumothorax Iatrogenic pneumothoraxIatrogenic pneumothorax TraumaticTraumatic CatamenialCatamenial
Summary SlideSummary Slide
Summary SlideSummary Slide
Summary SlideSummary Slide
Summary SlideSummary Slide
Primary Spontaneous Primary Spontaneous PneumothoraxPneumothorax
Felt to arise from sub pleural blebsFelt to arise from sub pleural blebs Associated with smokingAssociated with smoking Patients tend to be taller and thinnerPatients tend to be taller and thinner Usually occurs when the patient is at restUsually occurs when the patient is at rest Diagnosis confirmed by chest x rayDiagnosis confirmed by chest x ray
• % pneumothorax= 100[1-lung% pneumothorax= 100[1-lung33/hemithorax/hemithorax33)) Recurrence rate of 39% on ipsilateral side Recurrence rate of 39% on ipsilateral side
and 15% on contralateral sideand 15% on contralateral side• Second recurrence rate of 50%Second recurrence rate of 50%
Treatment of Primary Spontaneous Treatment of Primary Spontaneous PneumothoraxPneumothorax
ObservationObservation Supplemental oxygenSupplemental oxygen Simple aspirationSimple aspiration Chest tubeChest tube Thoracoscopy, bleb resection, and Thoracoscopy, bleb resection, and
pleurodesis (usually reserved for pleurodesis (usually reserved for recurrent disease)recurrent disease)• Recurrence rates of 3-4 % after Recurrence rates of 3-4 % after
thoracoscopythoracoscopy
Indications for surgery in primary Indications for surgery in primary spontaneous pneumothoraxspontaneous pneumothorax
First episodeFirst episodeProlonged air leakProlonged air leak
Incompeleted reexpansion of lungIncompeleted reexpansion of lung
Associated single large bullaAssociated single large bulla
Occupational hazardOccupational hazard
Absence of medical facilityAbsence of medical facility
Tension pneumothoraxTension pneumothorax
HemopneumothoraxHemopneumothorax
Bilateral pneumothoraxBilateral pneumothorax Second episodeSecond episode
Ipsilateral recurrenceIpsilateral recurrence
Contralateral pneumothorax Contralateral pneumothorax
Secondary Spontaneous Secondary Spontaneous PneumothoraxPneumothorax
EtiologyEtiology• COPDCOPD
Cystic fibrosisCystic fibrosis
• Interstitial lung disease such as Interstitial lung disease such as sarcoidosis or eosinophilic granulomasarcoidosis or eosinophilic granuloma
• PneumocystisPneumocystis Recurrence rates higher that for Recurrence rates higher that for
primary spontaneous pneumothoraxprimary spontaneous pneumothorax
Treatment of Secondary Treatment of Secondary PneumothoraxPneumothorax
Chest tubeChest tube Pleurodesis with first event with or Pleurodesis with first event with or
without thoracoscopywithout thoracoscopy
Summary SlideSummary Slide
Summary SlideSummary Slide
Iatrogenic PneumothoraxIatrogenic Pneumothorax
Transthroacic needle aspiration – Transthroacic needle aspiration – 20% 20%
Mechanical ventilationMechanical ventilation ThoracentesisThoracentesis Central line placementCentral line placement Transbronchial lung biopsyTransbronchial lung biopsy
Treatment of Iatrogenic Treatment of Iatrogenic PneumothoraxPneumothorax
Minimal symptoms and less that 15% Minimal symptoms and less that 15% pneumothorax: observepneumothorax: observe
Symptomatic or > 15 % : aspiration Symptomatic or > 15 % : aspiration or chest tubeor chest tube
For patients on mechanical For patients on mechanical ventilation: chest tubeventilation: chest tube
Traumatic PneumothoraxTraumatic Pneumothorax Penetrating or non-penetrating traumaPenetrating or non-penetrating trauma 40% are occult to plain chest film and are 40% are occult to plain chest film and are
discovered with CTdiscovered with CT Consider rare but catastrophic diagnoses Consider rare but catastrophic diagnoses
that require immediate thoracotomythat require immediate thoracotomy• Rupture of the tracheaRupture of the trachea• Rupture of the esophagusRupture of the esophagus
Treatment is usually with a chest tube. If Treatment is usually with a chest tube. If the pneumothorax is small and the patient the pneumothorax is small and the patient is not in the ventilator, observation may is not in the ventilator, observation may be consideredbe considered
Chylous Pleural EffusionChylous Pleural Effusion Defined by the presence of chyle (lymph) in the Defined by the presence of chyle (lymph) in the
pleural space. pleural space. DiagnosisDiagnosis
• Appearance often milky. Must differentiate chylous from Appearance often milky. Must differentiate chylous from chyliform effusionchyliform effusion
• Chemical confirmationChemical confirmation Triglyceride > 110 mg/dL Triglyceride > 110 mg/dL If triglyceride is between 50-110 mg/dL, send fluid for If triglyceride is between 50-110 mg/dL, send fluid for
lipoprotein electrophoresis. Chylomicrons confirms a lipoprotein electrophoresis. Chylomicrons confirms a chylothoraxchylothorax
If triglyceride is < 50, it is not chylousIf triglyceride is < 50, it is not chylous• Chyliform effusion has elevated cholesterol and occurs Chyliform effusion has elevated cholesterol and occurs
in long standing effusions. in long standing effusions.
Causes of Chylous EffusionCauses of Chylous Effusion
TumorTumor 54%54%• LymphomaLymphoma
TraumaTrauma 25%25%• SurgicalSurgical• OtherOther
IdiopathicIdiopathic 15%15% MiscellaneousMiscellaneous 6% 6%
Treatment of Traumatic Chylous Treatment of Traumatic Chylous EffusionEffusion
• Pleuroperitineal shuntsPleuroperitineal shunts• Chest tube: Caution that the patient Chest tube: Caution that the patient
may become malnourished. may become malnourished. Therefore, chyle flow is reduced by Therefore, chyle flow is reduced by GI rest and the use of parenteral GI rest and the use of parenteral nutritionnutrition
• Chemical pleurodesisChemical pleurodesis• Thoracotomy or thoracoscopy and Thoracotomy or thoracoscopy and
ligation of the thoracic duct. ligation of the thoracic duct.
Treatment of Non-traumatic Treatment of Non-traumatic Chylous EffusionsChylous Effusions
• Treat underlying lymphoma or Treat underlying lymphoma or carcinomacarcinoma
• If ineffective, then insert a If ineffective, then insert a pleuroperitineal shuntpleuroperitineal shunt
Lymphangioleiomyomatosis (LAM)Lymphangioleiomyomatosis (LAM)
Rare disease of women of reproductive ageRare disease of women of reproductive age A disease of proliferation of smooth muscle-like A disease of proliferation of smooth muscle-like
cells and affects the small airways, pulmonary cells and affects the small airways, pulmonary microvasculature, and lymphaticsmicrovasculature, and lymphatics
Causes airway obstruction, cystic changes in the Causes airway obstruction, cystic changes in the lung, and chylous effusionslung, and chylous effusions
Typical patient is a young woman with interstitial Typical patient is a young woman with interstitial disease on chest film, hyperinflated lungs (from disease on chest film, hyperinflated lungs (from air trapping) on pulmonary function, and a air trapping) on pulmonary function, and a chylous effusion. chylous effusion.
Treatment with antiestrogen therapy Treatment with antiestrogen therapy (medroxyprogesterone, tamoxifen) or (medroxyprogesterone, tamoxifen) or transplantationtransplantation
Chyliform EffusionsChyliform Effusions
Milky pleural fluid due to elevated Milky pleural fluid due to elevated cholesterol of lecithin-globulin cholesterol of lecithin-globulin complexescomplexes
Most commonly associated with Most commonly associated with tuberculosis, rheumatoid arthritis, tuberculosis, rheumatoid arthritis, therapeutic pneumothoraxtherapeutic pneumothorax
HemothoraxHemothorax Pleural fluid hematocrit greater that 50% that of Pleural fluid hematocrit greater that 50% that of
peripheral bloodperipheral blood Causes Causes
• Traumatic (penetrating or non-penetrating)Traumatic (penetrating or non-penetrating)• Iatrogenic (thoracic surgery or line placement)Iatrogenic (thoracic surgery or line placement)• Non traumatic (from metastatic pleural disease), Non traumatic (from metastatic pleural disease),
spontaneous rupture of an intrathoracic vessel, bleeding spontaneous rupture of an intrathoracic vessel, bleeding disordersdisorders
• Complication of anticoagulant therapyComplication of anticoagulant therapy Treatment is immediate chest tube (both to Treatment is immediate chest tube (both to
evacuate the fluid and monitor for additional evacuate the fluid and monitor for additional bleeding) bleeding)
Complications of HemothoraxComplications of Hemothorax
Retention of clotted blood in the Retention of clotted blood in the thorax (causing restriction) thorax (causing restriction)
InfectionInfection Effusion (usually self limited)Effusion (usually self limited) Fibrothorax (occurs in less that 1% of Fibrothorax (occurs in less that 1% of
hemothoraces. Decortication is hemothoraces. Decortication is necessary)necessary)
top related